1. Home
  2. AMPH vs FPF Comparison

AMPH vs FPF Comparison

Compare AMPH & FPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • FPF
  • Stock Information
  • Founded
  • AMPH 1996
  • FPF 2013
  • Country
  • AMPH United States
  • FPF United States
  • Employees
  • AMPH N/A
  • FPF N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • FPF Trusts Except Educational Religious and Charitable
  • Sector
  • AMPH Health Care
  • FPF Finance
  • Exchange
  • AMPH Nasdaq
  • FPF Nasdaq
  • Market Cap
  • AMPH 1.3B
  • FPF 1.1B
  • IPO Year
  • AMPH 2014
  • FPF N/A
  • Fundamental
  • Price
  • AMPH $28.29
  • FPF $18.34
  • Analyst Decision
  • AMPH Hold
  • FPF
  • Analyst Count
  • AMPH 3
  • FPF 0
  • Target Price
  • AMPH $43.50
  • FPF N/A
  • AVG Volume (30 Days)
  • AMPH 569.1K
  • FPF 186.7K
  • Earning Date
  • AMPH 05-07-2025
  • FPF 01-01-0001
  • Dividend Yield
  • AMPH N/A
  • FPF 8.08%
  • EPS Growth
  • AMPH 17.69
  • FPF N/A
  • EPS
  • AMPH 3.06
  • FPF N/A
  • Revenue
  • AMPH $731,967,000.00
  • FPF N/A
  • Revenue This Year
  • AMPH $2.60
  • FPF N/A
  • Revenue Next Year
  • AMPH $9.42
  • FPF N/A
  • P/E Ratio
  • AMPH $9.25
  • FPF N/A
  • Revenue Growth
  • AMPH 13.59
  • FPF N/A
  • 52 Week Low
  • AMPH $25.89
  • FPF $13.91
  • 52 Week High
  • AMPH $53.96
  • FPF $18.09
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 43.50
  • FPF 40.03
  • Support Level
  • AMPH $28.01
  • FPF $18.39
  • Resistance Level
  • AMPH $29.18
  • FPF $18.70
  • Average True Range (ATR)
  • AMPH 0.79
  • FPF 0.17
  • MACD
  • AMPH 0.35
  • FPF -0.01
  • Stochastic Oscillator
  • AMPH 72.95
  • FPF 34.55

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About FPF First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.

Share on Social Networks: